1284 related articles for article (PubMed ID: 2169393)
1. Recovery of the rat hypothalamic-pituitary-adrenal axis after discontinuation of prolonged treatment with the synthetic glucocorticoid agonist dexamethasone.
Calogero AE; Kamilaris TC; Johnson EO; Tartaglia ME; Chrousos G
Endocrinology; 1990 Oct; 127(4):1574-9. PubMed ID: 2169393
[TBL] [Abstract][Full Text] [Related]
2. Corticotropin secretagogues facilitate recovery of the hypothalamus-pituitary-adrenal axis suppressed by prolonged treatment with dexamethasone.
Huang TS
Metabolism; 1994 May; 43(5):544-8. PubMed ID: 8177041
[TBL] [Abstract][Full Text] [Related]
3. Concomitant infusion of ovine corticotropin-releasing hormone does not prevent suppression of the hypothalamus-pituitary-adrenal axis by dexamethasone in male rats.
Huang TS
J Endocrinol Invest; 1997; 20(7):393-6. PubMed ID: 9309537
[TBL] [Abstract][Full Text] [Related]
4. Desensitization of the hypothalamic-pituitary-adrenal axis following prolonged administration of corticotropin-releasing hormone or vasopressin.
Tizabi Y; Aguilera G
Neuroendocrinology; 1992 Nov; 56(5):611-8. PubMed ID: 1336816
[TBL] [Abstract][Full Text] [Related]
5. Chronic brain glucocorticoid receptor blockade enhances the rise in circadian and stress-induced pituitary-adrenal activity.
van Haarst AD; Oitzl MS; Workel JO; de Kloet ER
Endocrinology; 1996 Nov; 137(11):4935-43. PubMed ID: 8895366
[TBL] [Abstract][Full Text] [Related]
6. Blunted pituitary-adrenocortical stress response in adult rats following neonatal dexamethasone treatment.
Felszeghy K; Bagdy G; Nyakas C
J Neuroendocrinol; 2000 Oct; 12(10):1014-21. PubMed ID: 11012843
[TBL] [Abstract][Full Text] [Related]
7. The muscarinic cholinergic agonist arecoline stimulates the rat hypothalamic-pituitary-adrenal axis through a centrally-mediated corticotropin-releasing hormone-dependent mechanism.
Calogero AE; Kamilaris TC; Gomez MT; Johnson EO; Tartaglia ME; Gold PW; Chrousos GP
Endocrinology; 1989 Nov; 125(5):2445-53. PubMed ID: 2551652
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the hypothalamic-pituitary-adrenal axis during water deprivation.
Aguilera G; Lightman SL; Kiss A
Endocrinology; 1993 Jan; 132(1):241-8. PubMed ID: 8380375
[TBL] [Abstract][Full Text] [Related]
9. Feedback sensitivity of the rat hypothalamo-pituitary-adrenal axis and its capacity to adjust to exogenous corticosterone.
Akana SF; Scribner KA; Bradbury MJ; Strack AM; Walker CD; Dallman MF
Endocrinology; 1992 Aug; 131(2):585-94. PubMed ID: 1322275
[TBL] [Abstract][Full Text] [Related]
10. Hypothalamic and suprahypothalamic effects of prolonged treatment with dexamethasone in the rat.
Calogero AE; Liapi C; Chrousos GP
J Endocrinol Invest; 1991 Apr; 14(4):277-86. PubMed ID: 1650804
[TBL] [Abstract][Full Text] [Related]
11. Effects of short and long duration hypothyroidism and hyperthyroidism on the plasma adrenocorticotropin and corticosterone responses to ovine corticotropin-releasing hormone in rats.
Kamilaris TC; DeBold CR; Johnson EO; Mamalaki E; Listwak SJ; Calogero AE; Kalogeras KT; Gold PW; Orth DN
Endocrinology; 1991 May; 128(5):2567-76. PubMed ID: 1850357
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the hypothalamic-pituitary-adrenal axis in children with leukemia before and after 6 weeks of high-dose glucocorticoid therapy.
Kuperman H; Damiani D; Chrousos GP; Dichtchekenian V; Manna TD; Filho VO; Setian N
J Clin Endocrinol Metab; 2001 Jul; 86(7):2993-6. PubMed ID: 11443157
[TBL] [Abstract][Full Text] [Related]
13. Experimentally-induced hyperthyroidism is associated with activation of the rat hypothalamic-pituitary-adrenal axis.
Johnson EO; Kamilaris TC; Calogero AE; Gold PW; Chrousos GP
Eur J Endocrinol; 2005 Jul; 153(1):177-85. PubMed ID: 15994759
[TBL] [Abstract][Full Text] [Related]
14. Chronic melatonin treatment counteracts glucocorticoid-induced dysregulation of the hypothalamic-pituitary-adrenal axis in the rat.
Konakchieva R; Mitev Y; Almeida OF; Patchev VK
Neuroendocrinology; 1998 Mar; 67(3):171-80. PubMed ID: 9630434
[TBL] [Abstract][Full Text] [Related]
15. Combined dexamethasone/CRH test in rats: hypothalamo-pituitary-adrenocortical system alterations in aging.
Hatzinger M; Reul JM; Landgraf R; Holsboer F; Neumann I
Neuroendocrinology; 1996 Nov; 64(5):349-56. PubMed ID: 8930935
[TBL] [Abstract][Full Text] [Related]
16. Chronic stimulation of the pituitary-adrenal axis in rats by interleukin-1 beta infusion: in vivo and in vitro studies.
Sweep CG; van der Meer MJ; Hermus AR; Smals AG; van der Meer JW; Pesman GJ; Willemsen SJ; Benraad TJ; Kloppenborg PW
Endocrinology; 1992 Mar; 130(3):1153-64. PubMed ID: 1311230
[TBL] [Abstract][Full Text] [Related]
17. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R
J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
[TBL] [Abstract][Full Text] [Related]
18. Corticotrope response to removal of releasing factors and corticosteroids in vivo.
Dallman MF; Makara GB; Roberts JL; Levin N; Blum M
Endocrinology; 1985 Nov; 117(5):2190-7. PubMed ID: 2995008
[TBL] [Abstract][Full Text] [Related]
19. Effects of fetal ethanol exposure on pituitary-adrenal sensitivity to secretagogues.
Osborn JA; Yu C; Stelzl GE; Weinberg J
Alcohol Clin Exp Res; 2000 Jul; 24(7):1110-9. PubMed ID: 10924017
[TBL] [Abstract][Full Text] [Related]
20. Effects of short-term dexamethasone treatment during pregnancy on the development of the immune system and the hypothalamo-pituitary adrenal axis in the rat.
Bakker JM; Schmidt ED; Kroes H; Kavelaars A; Heijnen CJ; Tilders FJ; van Rees EP
J Neuroimmunol; 1995 Dec; 63(2):183-91. PubMed ID: 8550816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
